Physician
Psychiatry
Dr. Fred D. Sheftell, MD
|
|
Give Review
Fred Sheftell is an expert in the field of Psychiatry. Doctor Fred D. Sheftell, MD has written publications. He has 100 publications published with PubMed. The lastest publication is: '[Clinical characteristics of migraine without aura].'
Publications
- Depression and Anxiety in Episodic and Chronic Cluster Headache: A Pilot Study.
- Naming Migraine and Those Who Have It.
- Best practices in publishing and the American Headache Society.
- Ten years of rizatriptan: from development to clinical science and future directions.
- Moving forward - essential questions for the next 10 years.
- Headache attributed to hypothyroidism.
- Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
- Understanding the headache patient with complex psychiatric comorbidities: a headache specialist's perspective.
- Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.
- Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
- Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?
- Optimizing the diagnosis and treatment of migraine.
- Clomiphene citrate as a new treatment for SUNCT: hormonal manipulation for hypothalamic-influenced trigeminal autonomic cephalalgias.
- The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alte...
- Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rap...
- Abrupt onset and termination of cutaneous allodynia (central sensitization) during attacks of SUNCT.
- Assessment of adverse events associated with triptans--methods of assessment influence the results.
- Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.
- Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
- Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria.
- The effect of weather on headache.
- Simple and efficient recognition of migraine with 3-question headache screen.
- Analgesic use: a predictor of chronic pain in medication overuse headache: the Head-HUNT study.
- Consequences of transforming measures of efficacy for acute therapies: 5-HT agonists as a worked example.
- Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care.
- Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.
- Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
- Migraine with aura versus migraine without aura: pain intensity and associated symptom intensities after placebo.
- Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application.
- Mechanisms of action of the 5-HT1B/1D receptor agonists.
- Chronic daily headache: identification of factors associated with induction and transformation.
- Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT(1B/1D) agonist efficacy in migraine.
- Ethical considerations in cluster headache research.
- New paradigms in the recognition and acute treatment of migraine.
- Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification.
- Post-traumatic stress disorder, drug abuse and migraine: new findings from the National Comorbidity Survey Replication (NCS-R).
- Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communication Study, phase II.
- Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group.
- Zolmitriptan (Zomig).
- Sumatriptan: a decade of use and experience in the treatment of migraine.
- A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT).
- Intranasal medications for the treatment of migraine and cluster headache.
- The triptan formulations : how to match patients and products.
- The pathophysiology of migraine.
- New migraine preventive options: an update with pathophysiological considerations.
- Hemicrania continua: a report of ten new cases.
- Communicating the right therapy for the right patient at the right time: acute therapy.
- Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.
- Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials.
- Direct-to-consumer advertising of OTC agents under current ftc regulations: concerns and comment.
- Economic implications of early treatment of migraine with sumatriptan tablets.
- A comparison of MMPI personality data and frontalis electromyographic readings in two groups of daily headache sufferers.
- A comparison of MMPI personality data and frontalis electromyographic readings in migraine and combination headache patients.
- Over-the-counter analgesics and kidney disease.
- A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache.
- Office-based treatment of acute migraine with dihydroergotamine mesylate.
- Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
- Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers.
- Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence.
- [Clinical characteristics of migraine without aura].
- Recurrent headache: a neglected women's health problem.
- Characteristics of migraine visual aura.
- Role and impact of over-the-counter medications in the management of headache.
- Early and transient side effects of repetitive intravenous dihydroergotamine.
- Subcutaneous sumatriptan in a clinical setting: the first 100 consecutive patients with acute migraine in a tertiary care center.
- Geriatric headaches.
- Fiorinal with codeine in the treatment of tension headache--the contribution of components to the combination drug.
- Demographics of attendees at public education seminars.
- Naratriptan in the prophylaxis of transformed migraine.
- Differentiating the efficacy of 5-HT(1B/1D) agonists.
- Acute migraine treatment outcome measures: a clinician''s view.
- Rizatriptan in the treatment of migraine.
- Pharmacologic therapy, nondrug therapy, and counseling are keys to effective migraine management.
- Chronic paroxysmal hemicrania--case report of the second known definite occurrence in a male.
- Primary headaches: a convergence hypothesis.
- Long-term follow-up of patients treated for chronic daily headache with analgesic overuse.
- Hemicrania continua: comparison between two different classification systems.
- Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for...
- Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United St...
- Treatment of cluster headache with topiramate: effects and side-effects in five patients.
- Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
- MMPI personality profiles in patients with primary chronic daily headache: a case-control study.
- Primary chronic daily headache and its subtypes in adolescents and adults.
- Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)--a case report.
- Migraine: barriers for care.
- The quality of headache treatment in the United States: review and analysis of recent data.
- Migraine days decline with duration of illness in adolescents with transformed migraine.
- Headache attributed to psychiatric disorders.
- Persistent idiopathic facial pain responsive to topiramate.
- Field testing alternative criteria for chronic migraine.
- Headache prevention outcome and body mass index.
- Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations.
- Role of melatonin in the pathophysiology of migraine: implications for treatment.
- Which triptan for which patient?
- Migraine and silent infarcts. Are we making the proper decisions?
- Migraine and adiponectin: is there a connection?
- Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
- Square one: headache education for the medical student.
- Cluster headache treatment dilemmas: the experts respond.
Doctors Specialties
- Psychiatry
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Victor A. Altshul, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanders M. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Enenge A'Bodjedi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin O. Schechter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roumen N. Nikolov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simon J. Epstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael N. Sarezky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Florence A. Knox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irwin Potkewitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad R. Khan, MD |